Gender differences in the treatment of chronic ischemic heart disease: Prognostic implications

Fundamental and Clinical Pharmacology

Volumn 24, Issue 6, 2010, Pages 707-710

  Ciambrone, Graciana ^a   Kaski, Juan Carlos ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Angina; Prognosis; Sex; Treatment

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRAVASTATIN; SIMVASTATIN; SOTALOL;

ANGINA PECTORIS; ANGIOGRAPHY; CHRONIC DISEASE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; HEART FAILURE; HUMAN; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; PROGNOSIS; REVASCULARIZATION; REVIEW; SEX DIFFERENCE; STABLE ANGINA PECTORIS; TREATMENT RESPONSE;

CHRONIC DISEASE; FEMALE; HUMANS; MALE; MYOCARDIAL ISCHEMIA; PREVALENCE; PROGNOSIS; RISK FACTORS; SEX FACTORS; TREATMENT OUTCOME;

EID: 78349234326     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2009.00774.x     Document Type: Review

References (16)

1. MacLeod M.C., Finlayson A.R., Pell J.P., Findlay I.N. Geographic, demographic, and socioeconomic variations in the investigation and management of coronary heart disease in Scotland. Heart (1999) 81 252-256.
2. Morris R.W., Whincup P.H., Papacosta O., Walker M., Thomson A. Inequalities in coronary revascularization during 1990s: evidence from the British regional heart study. Heart (2005) 91 635-640.
3. Hemingway H., McCallum A., Shipley M., Manderbacka K., Martikainen P., Keskimäki I. Incidence and prognostic implications of stable angina pectoris among women and men. JAMA (2006) 295 1404-1411.
4. Lerner D.J., Kannel W.B. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am. Heart J. (1986) 111 383-390.
5. Watanabe C.T., Maynard C., Ritchie J.L. Comparison of short-term outcomes following coronary stenting in men versus women. Am. J. Cardiol. (2001) 88 848-852.
6. Vaccarino V., Lin Z.Q., Kasl S.V. et al. Gender differences in recovery after coronary artery bypass surgery. J. Am. Coll. Cardiol. (2003) 41 307-314.
7. Roeters van Lennep J.E., Zwinderman A.H., Roeters van Lennep H.W.O. et al. Gender differences in diagnosis and treatment of coronary artery disease from 1881 to 1997 No evidence for the Yentl Syndrome. Eur. Heart J. (2000) 21 911-918.
8. Juul-Moller S., Edvardsson N., Jahnmatz B., Rosen A., Sorensen S., Omblus R. for the Swedish Angina Pectoris Aspirin Trial (SAPAT) Group. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. Lancet. (1992) 340 1421-1425.
9. The Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet.(1994) 344:1383-1389.
10. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomized placebo-controlled trial. Lancet. (2002) 360 7-22.
11. Sacks F.M., Pfeffer M.A., Moye L.A. et al. for the Cholesterol and Recurrent Events Trial Investigators. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N. Engl. J. Med..(1996) 335 1001-1009.
12. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N. Engl. J. Med.. (1998) 339 1349-1357.
13. Shepherd J., Blauw G.J., Murphy M.B. et al. for the PROSPER Study Group (PROspective Study of Pravastatin in the Elderly at Risk). Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomized controlled trial. Lancet. (2002) 360:1623-1630.
14. Boden W.E., O'Rourke R.A., Teo K.K. et al. for the COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N. Engl. J. Med. (2007) 356 1503-1516.
15. Daly C., Clemens F., Lopez Sendon J. et al. on behalf of the Euro Heart Survey Investigators. Gender differences in the management and clinical outcome of stable angina. Circulation (2006) 113 490-498.
16. Sekhri N., Timmis A., Chen R. et al. Inequity of access to investigation and effect on clinical outcomes: prognostic study of coronary angiography for suspected stable angina pectoris. BMJ (2008) 336 1058-1061.